Elanco Animal Health: Credelio Receives FDA Emergency Use Authorization
Elanco Animal Health Incorporated has received Emergency Use Authorization (EUA) from the U.S. Food and Drug Administration (FDA) for Credelio (lotilaner) to treat New World screwworm (NWS) infestations in dogs.
This is the first EUA ever granted by the Agency for NWS in dogs, issued prior to the fly being detected in the U.S.
- Confirmed cases of NWS have been detected less than 70 miles south of the U.S.-Mexico border.
- The EUA allows veterinarians and pet owners to have a ready-now treatment option if the fly enters the U.S.
The action prepares veterinarians and pet owners with treatment options.
Author's summary: Elanco's Credelio receives FDA EUA for NWS in dogs.
More News
- Sun Pharma Laboratories gets CDSCO Panel nod to study Oral Semaglutide Tablets
- I Was Driving My Toyota Tundra At 70 MPH When My Securely Latched Tonneau Cover Suddenly Flew Off With A Loud Pop, Breaking Into Pieces On The Highway
- Lakers’ Jaxson Hayes sits out against Timberwolves
- Satish Shah, Sarabhai vs Sarabhai's Beloved Indravadan, Dies At 74
- Yes, I'm in favor of white evangelicals being honest – Baptist News Global
- Satish Shah, Veteran Actor and Comedy Icon, Passes Away at 7
- CDSCO Ends Emergency-Use Authorization of Baricitinib for COVID-19 Treatment
- Satish Shah, Sarabhai vs Sarabhai's Beloved Indravadan, Dies At 74
- CDSCO Panel Rejects Troikaa Pharma's High-Strength Paracetamol Injection Citing Safety Concerns
- I Drove The 2026 Mazda CX-50 Hybrid Premium Plus After Owning The 2025 Model And Found The Reduced Engine Drone And Added Heated Steering Wheel Aren't Worth Trading In For